A week of state-backed moves Pharmaceuticals: The Ministry of Industry and Mines has reiterated the need for Algerian drugmakers to join the WHO’s prequalification program, a step that could open export markets but requires heavy compliance costs. Culture/Politics: Wildfire compensation decisions have begun rolling out to affected homeowners, while the Justice Ministry has installed new … Read more
Pharma Push: WHO Prequalification as Export Leverage Why it matters for entrepreneurs: – WHO prequalification opens direct access to public procurement in 45 low-income countries, bypassing middlemen. – Kouidri Pharma and Sotepharma are the front-runners, with 30% of their production already earmarked for export. – Barriers remain: Logistics costs add 15-20% to export prices, and … Read more
Algeria’s pharmaceutical industry is on the brink of a major breakthrough. This week, Health Minister Abdelhakim Kouidri urged local manufacturers to accelerate their participation in the World Health Organization’s (WHO) prequalification program, a stamp of approval that could open doors to lucrative global contracts worth $100 billion annually in medicines and vaccines. The move comes … Read more
Algeria’s growing role as a medical hub has drawn foreign-trained doctors—especially from Cuba—while local entrepreneurs and investors eye opportunities in a sector long dominated by state-run firms. The influx of international medical professionals, combined with recent foreign investment in pharmaceuticals, signals a shift that could reshape Algeria’s healthcare landscape and create new business avenues for … Read more
Algeria has achieved malaria-free certification from the World Health Organization (WHO), marking a significant milestone in public health after decades of sustained efforts. The announcement, made recently by the WHO, recognizes Algeria’s elimination of the disease within its borders, a feat that places it among the few countries globally to have achieved this status. The … Read more
Algeria has reduced the prevalence of common diseases in rural areas by nearly 30% since 2015, according to BORGEN Magazine. The improvement stems from a government-led expansion of primary healthcare centres and a parallel boost in domestic pharmaceutical production. For entrepreneurs and business founders, the shift opens new opportunities in logistics, digital health, and local … Read more
Algeria’s Ministry of Pharmaceutical Industry has signed a cooperation agreement with Danish pharmaceutical giant Novo Nordisk to increase domestic insulin production, a move that could reshape the country’s diabetes care market and create new opportunities for local entrepreneurs and the Algerian diaspora. The agreement, signed this week in Algiers, outlines plans to establish Algeria’s first … Read more
A Strategic Alliance to Overhaul Algeria’s Healthcare System The ground has been broken on Algeria’s first major joint venture hospital—a collaboration between Algerian authorities, Qatar Investment Authority, and German medical technology firms. This project marks a turning point for a healthcare sector long constrained by reliance on imports and outdated infrastructure. While official details on … Read more
The Algerian Ministry of Health’s recent meeting with the African Union Commission marks a pivotal moment for the country’s pharmaceutical industry. The discussions, held on March 31, 2026, centered on Algeria’s growing self-sufficiency in drug production and its potential to serve as a regional manufacturing hub. With local production now covering 60% of national demand—up … Read more